Mechanical |
Difficulty in retaining locally delivered therapeutics during normal movements or change of dressing. |
Protected delivery (i.e., patch delivery or bandage based). |
Oxidative stress |
Free radicals generated by uncontrolled oxidative stress can cause cellular damage and death. |
Deferoxamine and other free radical scavengers have been shown to reduce oxidative stress in wounds. |
Enzymatic |
Proteases present during normal and pathological wound healing degrade growth factors. |
Controlled and sustained release using drug-delivery systems. |
Hypoxia/ischemia |
Arterial or venous insufficiency impairing blood supply to injured tissue; edema impairing oxygen diffusion to injured tissue. |
Hyperbaric oxygen therapy, negative pressure wound therapy, and pro-angiogenic therapeutics. |
Infected/necrotic tissue |
Infected tissue is chronically inflamed and unable to progress through phases of wound healing; necrotic tissue lacks the ability to heal and is prone to infection. |
Debridement, systemic antibiotics, and antimicrobial dressings. |